Loading organizations...
§ Venture Capital · Shanghai, Shanghai, China
Venture capital investor funding biotechnology companies developing CAR-T immunotherapies for cancer.
JIC GenesisFountain Healthcare Ventures operates as a venture capital investor, specializing in early-stage biotechnology companies that develop innovative therapeutic solutions, with a particular emphasis on oncology. The firm's investment thesis centers on advancements in CAR-T immunotherapies for various cancers, including those targeting solid tumors. A notable transaction includes their participation in the $30 million Series B financing round for portfolio company CARsgen Therapeutics, which was publicly announced in January 2016. This significant funding round attracted co-investors such as KTB Ventures, Jolly Innovation Ventures, and Kaitai Capital, underscoring the collaborative nature of their investment strategy. Information concerning JIC GenesisFountain Healthcare Ventures' specific founding year and its initial founders is not publicly disclosed. Its business model centers on venture capital firm that invests in early-stage healthcare startups, funding details unknown.
JIC GenesisFountain Healthcare Ventures has 1 tracked investment across 1 company. The latest tracked deal is $30.0M Series B in CARsgen Therapeutics in January 2016.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 25, 2016 | CARsgen Therapeutics | $30.0M Series B | Jolly Innovation Ventures, CHI Hoon Hyun | Kaitai Capital |